Ex-Merck VP Says No Proof He Lied About Vioxx Study
The former vice president of Merck & Co. Inc. has urged a New Jersey federal court to dismiss a securities fraud class action, saying he did not lie to shareholders about...To view the full article, register now.
Already a subscriber? Click here to view full article